GIP and non-small cell lung carcinoma: From October 2001 to July 2006, a total of 433 stage IIIB–IV NSCLC patients were enrolled and randomly assigned to one of the four treatment regimens: GP (n=106), GN (n=106), GIP (n=110) and GIN (n=111), at 15 participating Italian centres.